MedTrace Logo

Active Monitoring And Determinants of Incidence Infection of COVDI-19

NCT04326400 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-04-01

No results posted yet for this study

Summary

7\. Objectives To apply e-health methods to perform active monitoring and assess determinants of incident Infection of COVID-19 in a hospital population.

8\. Study design Prospective, Single-centre, observational clinical study. 9. Disease or disorder under study Healthy people in risk of COVID-19 infection. 10. Main variable. Symptoms related to infection caused by SARS-Cov2. 11. Study population and total number of patients Men and women in general god health status aged between 18 and 80 years that currently are employees of Hospital de La Princesa .

12\. Duration of treatment Each subject will be monitored, since its recruitment, for a period of 12 weeks.

13\. Timetable and expected date of completion The overall duration of the study is estimated at about 6 months, from patient recruitment to the last data recorded by last subject. The aim is to carry out this study from March 2020 onwards.

Conditions

  • Coronavirus Infection

Sponsors & Collaborators

  • Fundación Teófilo Hernando, Spain

    lead OTHER

Principal Investigators

  • Joan Soriano, MD, PhD · Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-23
Primary Completion
2020-07-20
Completion
2020-09-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326400 on ClinicalTrials.gov